A 72-year-old patient with a bypass graft skips her 6-month duplex. She feels fine and forgets the reminder card on the counter. Six weeks later, she lands in the ER with graft thrombosis. The duplex would have caught the silent stenosis weeks earlier.
This pattern repeats every day across vascular practices. Roughly 30-40% of eligible patients miss their surveillance imaging windows. The cost is not just clinical. It is operational, financial, and reputational.
Most practices still rely on phone calls and mail. Staff dial through long lists, leave voicemails, and chase reschedules. Contact rates rarely climb past 60% on first attempt. Mail-based reminders fare even worse, with show rates stuck near 35%.
Meanwhile, the data sits ready inside Medstreaming. Procedure dates, surveillance windows, and follow-up rules are all structured and queryable. The gap is not data. The gap is outreach.
That gap is where a vascular surveillance imaging recall campaign SMS Medstreaming workflow shines. Curogram queries your EMR, sorts overdue patients by procedure, and sends text reminders elderly patients actually read. Responses flow back to the chart with consent and opt-out status logged.
Practices that switch see real numbers move. Based on our internal data, a 15-location pilot recovered $231,000 from one 48-hour campaign. Staff hours dropped 75-85%. Compliance audits got much simpler.
This guide shows how to recover lost imaging revenue and protect patient safety. We cover what breaks in manual recall, why Medstreaming alone cannot close the loop, and how SMS segmentation fills the gap. You will also see how to track results and stay HIPAA-clean.
If your vascular follow-up recall SMS plan still leans on phone calls, the next sections show what to fix first. The fixes work whether you run a single OBL or a multi-site cardiovascular group.
Vascular surveillance imaging is not optional. Duplex ultrasounds, annual carotid scans, and post-procedure CTs are clinical mandates. They catch silent stenosis, graft decline, and aneurysm growth before things turn dangerous.
For bypass grafts, duplex imaging at 6 weeks, 6 months, and yearly is the standard. For patients with prior carotid intervention, an annual scan is the baseline. Missing these scans is not a minor lapse. It is a clinical risk that ends in ER visits and emergency surgery.
The vascular patient population skews older. Median age sits between 65 and 75. Portal adoption in this group is often below 15%. Email goes unread. Mailed letters get lost in stacks of bills and junk mail.
These patients respond best to direct, immediate prompts. A phone call works. A text message works even better. The numbers prove it.
Mail-based reminders pull 30-40% show rates for surveillance imaging. Phone-based prep calls climb to 60-70% but cost massive staff hours. SMS reminders hit 75-85% with very little labor in return.
The clinical risk is real. A missed duplex lets graft stenosis go silent until it turns into thrombosis. A skipped carotid screening recall leaves stroke risk unchecked. The price gap between planned surveillance and an emergency thrombectomy tops $8,000 per patient.
Staff burden adds another layer. Each recall call takes 15-20 minutes. First-attempt voicemail rates hit 40-60%. A typical 1,500-patient cohort with 30% overdue means 450 patients to reach. That works out to 100-150 staff hours just to start the recall loop.
The financial side hurts even more. One missed duplex costs $600-$1,000 in facility fee revenue. One missed carotid scan costs $400-$700. A mid-market practice with 1,200 overdue patients yearly leaves $720K-$1.2M on the table. A 5-location group loses $3.6M-$6M each year.
SMS recall campaigns recover 30-35% of that lost volume. Based on our internal data, that means $180K-$250K back per location per year.
Staff fatigue is the quiet cost. One to two FTEs per cohort spend 15-20 hours a week on cold calls. Contact rates stall at 50-60%. Burnout and turnover rise. Patient interactions suffer because the staff doing them are exhausted.
|
Recall Method |
Show Rate |
Staff Hours/Week |
Revenue Capture |
|
Mail only |
30-40% |
Low |
Low |
|
Phone calls |
60-70% |
15-20 per FTE |
Medium |
|
SMS reminders |
75-85% |
2-3 |
High |
The takeaway is simple. Manual recall is expensive, slow, and leaves patients exposed. The only question is what to replace it with.
Medstreaming is the gold standard for vascular procedural documentation. It is built for specialist practices. It captures procedure dates, surveillance windows, imaging protocols, and risk levels with precision.
Medstreaming integrates with PACS systems and captures visual data alongside clinical notes. It holds the procedural context that general EHRs miss. Administrators can query the system for any procedure older than X days without a matching follow-up. That data sits ready in structured form, exportable via HL7 or REST APIs.
The strength stops at outreach. Medstreaming has no built-in patient segmentation. There is no bulk SMS engine. No central opt-in registry. No real-time appointment confirmation. No write-back path for patient responses.
The Fivos Patient Portal is the closest thing the platform offers. But the portal needs a login. Elderly vascular patients rarely sign up. Adoption sits under 15% in patients aged 65-75. The portal is a technical fix for a behavioral problem.
The platform was built to document procedures, not to text patients. That design choice was correct for its time. It just leaves a wide gap that practices have to fill another way.
Without automation, practices fall back on calls. One to two FTEs per 1,500-patient cohort spend 15-20 hours a week dialing. First-attempt contact lands at 50-60%. First-call reschedules happen only 10-15% of the time.
A second call goes out 3-7 days later. A third often follows. That three-touch process eats 30-45 hours a week per 1,500 patients. That is 1.5-2.5 FTEs dedicated to recall labor. Annual cost: $52,500-$112,500 per cohort.
Compliance risk piles up too. Without a single consent registry, proving HIPAA opt-in for SMS becomes hard. Audits find gaps. The phone log, portal, and EMR each hold a piece of the story, but no single source ties them together.
Data insight disappears in the shuffle. When a patient calls back after a recall attempt, the response lives in voicemail or the phone system. The admin scheduling the patient may skip the reason for delay. Communication preferences go unrecorded. The recall process never improves because the feedback loop is broken.
The Medstreaming patient recall problem is not a software flaw. It is a coverage gap. The platform documents what happens. Closing the gap takes a layer designed for outreach.
Think of it this way: Medstreaming is the chart. The chart cannot make a phone call or send a text on its own. You need a second tool that reads the chart, decides who to contact, and acts. That is the layer most practices are missing today.
The cost of leaving that layer empty is exactly what we covered in Section 1: missed scans, lost revenue, burned-out staff, and audit anxiety. The fix is not to replace Medstreaming. The fix is to add the outreach engine on top.
Curogram fills the layer Medstreaming was never meant to handle: patient outreach. It connects to your Medstreaming HL7 feed or REST API.
It queries the EMR nightly (or on demand) for overdue surveillance patients. It sorts them by procedure type. It sends SMS reminders built for each cohort. And it writes patient responses back into the chart.
The segmentation logic matters. A blanket text to all overdue patients does not work. Each group has a different clinical need and a different reason to come back.
Each text stays under 160 characters. Plain language, no jargon, but specific enough to remind the patient why the scan matters. The clinical context shows up without scaring anyone.
Real-world numbers back this up. Based on our internal research, a 15-location vascular practice ran a pilot using a vascular surveillance imaging recall campaign SMS Medstreaming workflow. Here is what came back:
|
Metric |
Pilot Result |
|
Overdue patients identified |
1,240 across 15 sites |
|
SMS delivery rate |
96% |
|
Response rate within 48 hours |
42% |
|
Reconversion (scheduled within 14 days) |
31% |
|
Patients scheduled |
385 |
|
Average imaging value |
$600 |
|
Net revenue recovered |
$231,000 |
|
Campaign cost (SMS + platform) |
$45 |
That is a single 48-hour campaign. Run quarterly, the same setup scales to $200K-$250K in annual recovery per location.
The consent layer is just as important as the send layer. Curogram keeps a central registry tied to each Medstreaming patient ID. Every SMS send, delivery attempt, bounce, reply, and opt-out is logged with a timestamp. An auditor can pull a one-page report for any patient. Consent date, all sends, delivery status, and responses live in one place.
The labor shift is just as big. A manual recall program eats 15-20 hours a week per cohort. A vascular follow-up recall SMS program drops that to 2-3 hours. That is a 75-85% cut in recall labor.
What replaces the calls? A dashboard. Admin staff watch four numbers in real time:
Patients who do not respond get added to a manual follow-up list. Staff make one targeted call instead of five blanket attempts. Labor goes where it actually moves the needle.
That registry matters for cardiac surveillance recall campaign workflows too. Cardiology practices that share infrastructure with vascular labs run the same surveillance schedules. The same SMS engine handles both.
How Curogram Closes the Gap Medstreaming Cannot
Curogram does not replace Medstreaming. It plugs into it. The integration runs through HL7 or REST API, depending on your setup. Patient demographics, procedure history, and surveillance windows flow from Medstreaming into Curogram. Patient responses flow back the other way.
That two-way sync is the part most messaging tools miss. A standalone SMS platform can send texts. It cannot tell your EMR that a patient asked about a reschedule, opted out, or confirmed the appointment. Curogram writes those events back to the Medstreaming patient record as structured data.
The platform was built with HIPAA in mind from day one. TLS 1.2 encrypts every payload in transit and at rest. Patient phone numbers stay hashed in batch-send workflows and are only decrypted at the moment of transmission. A Business Associate Agreement covers the data handling between Curogram and your practice.
Setup does not need a custom engineering project. Practices typically go live in 4-6 weeks. Curogram handles the Medstreaming connection, the consent registry build, and the SMS template library. Your team handles the patient list approval and the dashboard training.
The dashboard is where the value shows up day to day. Admin staff can filter overdue patients by modality, date range, location, or risk level. A single click triggers a segmented campaign. Reports export as PDF or CSV for board reviews and compliance audits.
The bigger picture: Curogram turns Medstreaming from a documentation tool into a closed-loop surveillance system. The data was always there. Now the outreach matches it.
Vascular surveillance is too important to leave to phone tag. The clinical data is clear. The financial data is clearer. Practices that stick with manual recall lose $200K-$250K per location every year.
Medstreaming gives you the data. It tracks procedures, surveillance windows, and follow-up rules with precision. What it does not do is reach patients. That outreach gap is where revenue and outcomes both slip.
A vascular surveillance imaging recall campaign SMS Medstreaming setup closes the loop. Curogram queries the EMR, segments patients by modality, and sends text reminders elderly patients actually read. Replies flow back to the chart. Consent and opt-out events get logged. Compliance audits get simpler.
The shift pays off in three places at once. Staff hours drop 75-85%. Revenue recovery hits $200K-$250K per location per year. Compliance documentation becomes audit-ready by default.
For OBL and ASC administrators, the math is hard to ignore. A 1,500-patient cohort with 450 overdue patients recovers about $81,000 per campaign. Run that quarterly and the annual impact scales fast. Platform costs run a fraction of the recovered revenue.
The clinical case is just as strong. Catching graft stenosis early prevents thrombectomy. Catching carotid plaque early prevents stroke. Every avoided ER visit is a patient who stayed safe and a downstream cost the practice never had to absorb.
The path forward is straightforward. Audit your Medstreaming overdue list. Map the modality segments. Pilot a 48-hour SMS campaign on the top 200 patients. Track delivery, response, and reconversion. Scale from there.
Reclaim the 15-20 hours your team spends each week chasing recall phone calls. Schedule a demo and watch Curogram segment your Medstreaming overdue list.